NCT01937533

Brief Summary

This study aims to develop the technique of Diffusion-Weighted Magnetic Resonance Imaging(DW-MRI)for the assessment of stage 1 cervical cancers. An endovaginal receiver coil has been designed and developed at the Institute of Cancer Research and Royal Marsden NHS Foundation Trust for use at high field strengths(3T). This will be used to evaluate if DW-MRI at 3T can be used to differentiate different histological characteristics within whole tumours and so determine if the technique could be of prognostic value. The study hypothesis is that this technique will be able to differentiate tumours with histological features known to be associated with poor prognosis (tumour type, grade and lymphovascular space invasion).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
236

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 29, 2013

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 9, 2013

Completed
23 days until next milestone

Study Start

First participant enrolled

October 2, 2013

Completed
5.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2019

Completed
Last Updated

January 28, 2020

Status Verified

January 1, 2020

Enrollment Period

5.6 years

First QC Date

August 29, 2013

Last Update Submit

January 27, 2020

Conditions

Keywords

Magnetic Resonance Imaging

Outcome Measures

Primary Outcomes (1)

  • To obtain histogram metrics(centiles, skew, kurtosis, entropy) for cervical cancer and compare them between histologically poor prognosis and good prognosis groups.

    Pixel by pixel analysis of ADC from tumour regions of interest will be used to derive histograms and the 10th, 25th, 50th, 75th and 90th centile values and histogram skew, kurtosis and entropy values for each tumour will be recorded. The number of regions will vary with tumour volume in each patient, given the mean size of lesions in patients studied in a pilot set, it is envisaged that we will analyse 1-5 regions of interest in each tumour. The data will be analysed separately by 2 observers who will be blinded to the histopathological characteristics and assuming good inter-observer agreement, an average of their results will be used for data analysis. The difference in mean centile ADC values of the distribution and the skewness, kurtosis and entropy values between squamous vs. adenocarcinoma, well/moderately differentiated vs. poorly differentiated tumour regions and the absence vs. the presence of lymphovascular space invasion in that region will be determined.

    1-2 months post imaging

Secondary Outcomes (1)

  • Establish ADC values associated with poor prognosis tumours

    Duration of study, 2-3 years

Study Arms (1)

Cervical Cancer

Patients with presumed early cervical cancer being considered for curative surgery

Procedure: Magnetic Resonance Imaging using an endovaginal receiver coil

Interventions

Eligibility Criteria

Age18 Years - 80 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Primary Care Clinic

You may qualify if:

  • All patients with presumed early stage cervical cancer being considered for curative surgery

You may not qualify if:

  • Ferromagnetic metal implants
  • claustrophobia (MRI incompatibility)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Institute of Cancer Research and Royal Marsden NHS Foundation Trust

Sutton, Surrey, SM2 5PT, United Kingdom

Location

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Nandita deSouza, Professor

    ICR

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Translational Imaging

Study Record Dates

First Submitted

August 29, 2013

First Posted

September 9, 2013

Study Start

October 2, 2013

Primary Completion

May 1, 2019

Study Completion

May 31, 2019

Last Updated

January 28, 2020

Record last verified: 2020-01

Locations